$0.450000
-0.03-5.86%
Pre-Market: Feb 5, 8:06 AM EDT
Comments
Loading...
Latest news for Sio Gene Therapies Inc (OTC:SIOX) Stock
Sio Gene Therapies Inc Stock (OTC: SIOX)
Categories: All
Thursday, February 09, 2023
Thursday, December 15, 2022
Wednesday, December 14, 2022
Thursday, December 01, 2022
Thursday, November 10, 2022
Thursday, August 11, 2022
Tuesday, June 14, 2022
Wednesday, June 08, 2022
Tuesday, June 07, 2022
Wednesday, June 01, 2022
Friday, May 06, 2022
Wednesday, May 04, 2022
Friday, April 29, 2022
Thursday, April 28, 2022
- Stocks That Hit 52-Week Lows On Thursday
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet
- Mid-Day Market Update: Teladoc Health Drops Following Q1 Results; Swvl Holdings Shares Jump
- 48 Stocks Moving In Thursday's Mid-Day Session
- Sio Gene Therapies shares are trading lower a...
- Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
- HC Wainwright & Co. Downgrades Sio Gene Thera...
- Sio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares Plunge
- The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Cantor Fitzgerald Downgrades Sio Gene Therapi...
- 28 Stocks Moving in Thursday's Pre-Market Session
Wednesday, April 27, 2022
Tuesday, March 08, 2022
Tuesday, February 22, 2022
Friday, February 18, 2022
Monday, February 14, 2022
Friday, February 11, 2022
Wednesday, February 09, 2022
Sunday, February 06, 2022
Wednesday, February 02, 2022
Tuesday, February 01, 2022
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Sio Gene Therapies shares are trading lower a...
- The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
- HC Wainwright & Co. Maintains Buy on Sio Gene...
- 10 Biggest Price Target Changes For Tuesday
- SVB Leerink Downgrades Sio Gene Therapies to ...
- Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition